The hour’s primary market signal is a geopolitical de-escalation; hopes for renewed diplomacy with Iran have pushed oil prices lower, softening U.S. Treasury yields and impacting energy-linked equities like Equinor and Ithaca. Amid this, corporate M&A activity is driving significant volatility, with AstraZeneca sliding on reports of merger talks with Bristol-Myers Squibb, while RWS jumped following an acquisition deal. Governance and sovereignty issues also surfaced: Acting Attorney General Todd Blanche rescinded a 1.8 billion dollar Department of Justice anti-weaponization fund, while renewable energy developer Avangrid canceled a controversial Washington state solar project following pushback from Indigenous nations over cultural site protection.